Creating
New Possibilities
We are committed to unlocking fundamentally different therapeutic approaches and creating new solutions through bold science and our unique drug discovery platform.
Named for the visual resemblance of a scholar rock to protein structures, Scholar Rock is advancing innovative treatments where protein growth factors are fundamental. Over the past decade, we have created a pipeline with the potential to advance the standard of care for neuromuscular disease and other conditions where growth factor-targeted drugs can play a transformational role.
Learn About Our ScienceScholar Rock works across therapeutic areas and shines new light on the overlooked to better target disease.
We are on a mission to discover, develop, and deliver life-changing therapies. We promote a spirit of curiosity and collaboration with the goal of achieving the best results for patients.
Exploration
Our Growing Pipeline
Follow our product candidates on their journeys to fighting serious diseases.
Spinal Muscular Atrophy
Apitegromab
Inhibit the activation of latent myostatin to promote a potentially clinically beneficial increase in muscle function
Oncology
SRK-181
Potential to overcome primary resistance to checkpoint inhibitors to reach a larger patient population
Anemias
Target RGMc—a co-receptor of BMP6—to potentially treat diseases associated with dysregulation of iron metabolism
Fibrosis
Inhibit TGFβ signaling to potentially offer a powerful new approach to suppressing pro-fibrotic signaling in multiple organs
October 8, 2024
Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants
October 7, 2024
Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 7, 2024
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
Events
View More EventsOctober 7, 2024
Scholar Rock Conference Call to Discuss Results from Phase 3 SAPPHIRE Study of Apitegromab
August 8, 2024
Scholar Rock 2Q 2024 Financial Results and Business Update Conference Call
Let’s Connect
Let’s talk science, let’s talk you! We’d love to hear from you and answer any questions you may have.
Join Our Team
We’re a group of thinkers and doers who fight disease from a new angle.